Back to Journals » Biologics: Targets and Therapy » Volume 9
Letter
Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,932 | Dovepress* | 10,489+ | 1,760 | 12,249 | |
PubMed Central* | 443 | 152 | 595 | ||
Totals | 10,932 | 1,912 | 12,844 | ||
*Since 19 February 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar